49 employees
Clade Therapeutics discovers and delivers next-generation cell medicines to improve the lives of patients.
2020
$87M
from 4 investors over 4 rounds
Clade Therapeutics raised $87M on November 3, 2021
Investors: LifeSci Venture Partners, Bristol-Myers Squibb, UK, Emerson Collective and Syncona Limited